KS-Development LLC has started developing a project for a plant for the production of APIS and its derivatives.
This high-tech project for the production of medicinal products at the Dorogobuzh plant is significant for the pharmaceutical industry nationwide and is included in the action plan for import substitution in the Russian pharmaceutical industry. This API is vital in the treatment of cardiovascular diseases and COVID-19. Currently, it is not produced on the territory of the Russian Federation.
The investor will allocate more than 2 billion rubles for the implementation of the project. The signed Agreement assumes that the new production facility will be opened in 2024. The social effect will be reflected in the creation of 120 new jobs.
